Medical News

RSS

Boston Heart receives $1.0M in additional tax incentives through Life Sciences Tax Incentive Program

Boston Heart Diagnostics Corporation, a pioneer in integrating next-generation diagnostics with personal nutrition and lifestyle programs for patients with or at risk for heart disease, has received $1.0 million in additional tax incentives through the Life Sciences Tax Incentive Program.

21 Feb 2014

AT Group to present new MatrixView PACStream platform at HiMSS 14

At the upcoming HiMSS 14, the AT Group exhibit, Booth #7384, presents MatrixView demonstrating its new turnkey PACS solution, MatrixView PACStream. The new MatrixView PACStream offering satisfies complex demands that are inherent in the movement and storage of medical imaging records and files.

21 Feb 2014

Viewpoints: Democrats turn tail; amending ACA is tough; Belgium takes hard stance on dying kids

Democrats in competitive races seem to have gotten hall passes to try to dissociate themselves from ObamaCare heading into the midterm elections, but the White House must be ruing some of the liberties their party comrades are taking with this new political independence. Witness the parade of Democrats pleading for more money for that great liberal anathema, Medicare Advantage (2/19).

21 Feb 2014

B3 Fit partners with GolinHarris to promote fitness instructor education programs

B3 Fit, Inc., creator of R.I.P.P.E.D., the hottest new workout system for total body fitness, has partnered with leading PR firm, GolinHarris, to promote its brand, fitness instructor education programs and the debut of its first home DVD.

21 Feb 2014

Impax Laboratories records adjusted net loss of $1.6 million in fourth quarter 2013

Impax Laboratories, Inc. today reported fourth quarter and full year ended December 31, 2013 results.

21 Feb 2014

Epidemiological studies demonstrate that diseases of central nervous system protect against cancer

Epidemiological studies demonstrate that diseases of the central nervous system such as Alzheimer, Parkinson and schizophrenia protect against cancer. The most remarkable example is Alzheimer's disease, which can reduce the risk of suffering from cancer by up to 50%.

21 Feb 2014

Ignyta reports preliminary results from ongoing Phase 1 clinical trial of RXDX-101

Ignyta, Inc., an oncology precision medicine biotechnology company, announced today that Justin Gainor, M.D., of the Massachusetts General Hospital Cancer Center, presented preliminary results from the ongoing Phase 1 dose escalation portion of a Phase 1/2 clinical trial of RXDX-101, Ignyta's proprietary oral tyrosine kinase inhibitor targeting solid tumor indications, at the International Association for the Study of Lung Cancer 14th Annual Targeted Therapies for the Treatment of Lung Cancer Meeting.

21 Feb 2014

GOP to challenge health law's definition of full-time worker

House Majority Leader Eric Cantor says Republicans will seek to change the law's definition of full-time workers to those logging more than 40 hours a week. Meanwhile, Sen. Chuck Grassley criticizes the administration's response to questions about whether insurers must accept third-party payments to cover an enrollee's premiums.

21 Feb 2014

Improving access to pediatric check-ups may increase parent's awareness about HPV vaccines

Improving access to pediatric check-ups may increase parental awareness of human papillomavirus (HPV) vaccines, a new nationwide study reveals.

21 Feb 2014

Convergent announces implementation of PatientQuest patient access solution at Moffitt Cancer Center

Convergent Revenue Cycle Management, Inc., leading provider of healthcare revenue cycle management and patient access solutions to hospitals across the nation, announces today the implementation of their PatientQuest patient access solution at H. Lee Moffitt Cancer Center & Research Institute (Moffitt Cancer Center) in Tampa, Florida. Moffitt Cancer Center is a Siemens Soarian customer.

20 Feb 2014

XenoPort reports net loss of $19.1 million for fourth quarter 2013

XenoPort, Inc. announced today its financial results for the fourth quarter and year ended December 31, 2013. Revenues for the fourth quarter were $2.9 million, compared to $0.5 million for the same period in 2012. Net loss for the fourth quarter was $19.1 million compared to net income of $3.0 million that resulted from a non-cash gain from XenoPort's litigation settlement with Glaxo Group Limited in the fourth quarter of 2012. At December 31, 2013, XenoPort had cash and cash equivalents and short-term investments of $58.7 million.

20 Feb 2014

CSL Behring enrolls first patient in phase III study of C1-INH for prevention of HAE attacks

CSL Behring today announced it has enrolled the first patient in COMPACT, an international phase III study of a volume-reduced, subcutaneous formulation of C1-esterase inhibitor oncentrate in patients with frequent hereditary angioedema attacks (NCT01912456).

20 Feb 2014

Standards of Care for the Addiction Specialist Physician released by ASAM

The American Society of Addiction Medicine announces its release of the Standards of Care for the Addiction Specialist Physician. Drafted by a diverse panel of addiction treatment providers, researchers and academicians and clinical outcomes experts, this document enumerates the essential treatment standards that should be met by a physician who manages or oversees the care of a patient with addiction and related disorders.

20 Feb 2014

In Maryland, support is solid for health overhaul, state's exchange

A new poll finds 55 percent of state residents back the federal health law, even as Maryland plans to spend $2 million to address a problem with the online insurance marketplace. In related news, the deadline is approaching for states to spend federal grants they received to set up exchanges.

20 Feb 2014

BDI Pharma joins with AstraZeneca to launch The MERREM Commitment Program

BDI Pharma today announced the launch of The MERREM Commitment Program with AstraZeneca, an assurance initiative offering customers security in product availability through contracted access to the original, branded MERREM I.V. from AstraZeneca.

20 Feb 2014

OrthoTrophix commences TPX-100 Phase 2 clinical study in knee osteoarthritis patients

OrthoTrophix, Inc., a privately held biopharmaceutical company, announced today that the Company started a Phase 2 clinical study of its cartilage repair therapeutic agent, TPX-100, with knee osteoarthritis patients in the U.S. The Company also announced that it had successfully closed the second and last tranche of its Series A preferred stock financing.

20 Feb 2014

TripleTree announces "call for applications" for 6th Annual TripleTree iAwards for Connected Health

TripleTree announces a "call for applications" for the 6th Annual TripleTree iAwards for Connected Health.

20 Feb 2014

DexCom reports 62% increase in product revenue for fourth quarter 2013

DexCom, Inc. today reported its audited financial results as of and for the quarter and fiscal year ended December 31, 2013.

20 Feb 2014

War of partisan words ramps up for election season

A conservative group and "dozens of Democrats" are adjusting their messages for the midterm election.

20 Feb 2014

Certify Data Systems to introduce latest version of HealthLogix platform at HIMSS 2014

Certify Data Systems, Inc., a pioneer of inspired technology for life, will introduce the latest version of HealthLogix, a next-generation, fully integrated population health management platform, at the 2014 Healthcare Information and Management Systems Society Conference and Exhibition in Orlando, Florida. Certify is a subsidiary of Humana Inc.

20 Feb 2014

Medical News

Boston Heart receives $1.0M in additional tax incentives through Life Sciences Tax Incentive Program

AT Group to present new MatrixView PACStream platform at HiMSS 14

Viewpoints: Democrats turn tail; amending ACA is tough; Belgium takes hard stance on dying kids

B3 Fit partners with GolinHarris to promote fitness instructor education programs

Impax Laboratories records adjusted net loss of $1.6 million in fourth quarter 2013

Epidemiological studies demonstrate that diseases of central nervous system protect against cancer

Ignyta reports preliminary results from ongoing Phase 1 clinical trial of RXDX-101

GOP to challenge health law's definition of full-time worker

Improving access to pediatric check-ups may increase parent's awareness about HPV vaccines

Convergent announces implementation of PatientQuest patient access solution at Moffitt Cancer Center

XenoPort reports net loss of $19.1 million for fourth quarter 2013

CSL Behring enrolls first patient in phase III study of C1-INH for prevention of HAE attacks

Standards of Care for the Addiction Specialist Physician released by ASAM

In Maryland, support is solid for health overhaul, state's exchange

BDI Pharma joins with AstraZeneca to launch The MERREM Commitment Program

OrthoTrophix commences TPX-100 Phase 2 clinical study in knee osteoarthritis patients

TripleTree announces "call for applications" for 6th Annual TripleTree iAwards for Connected Health

DexCom reports 62% increase in product revenue for fourth quarter 2013

War of partisan words ramps up for election season

Certify Data Systems to introduce latest version of HealthLogix platform at HIMSS 2014

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Latest News